January 21, 2022
According to Texas Biomed in June 2021, Olena Shtanko, Ph.D., “Staff Scientist at the Texas Biomedical Research Institute (Texas Biomed), has received more than $1 million from the National Institutes of Health (NIH) to explore different aspects of Ebola virus infection”.
The press release goes on to say, “Over the next two years, Shtanko will explore precisely how the Ebola virus hijacks a key immune cell in the body called macrophages” and “a possible alternative mode of spread — tunneling nanotubes, dynamic connections between cells, which allow cells to communicate by exchanging content over relatively long distances (up to 200 microns)”.
According to the Press Release on who and what Texas Biomed is, “Texas Biomed is one of the world’s leading independent biomedical research institutions dedicated to eradicating infection and advancing health worldwide through innovative biomedical research. Texas Biomed partners with researchers and institutions around the world to develop vaccines and therapeutics against viral pathogens causing AIDS, hepatitis, hemorrhagic fever, tuberculosis and parasitic diseases responsible for malaria and schistosomiasis disease. The Institute has programs in host-pathogen interaction, disease intervention and prevention, and population health to understand the links between infectious diseases and other diseases such as aging, cardiovascular disease, diabetes and obesity. For more information on Texas Biomed, go to www.TxBiomed.org.”
access the entire press release here
